103 related articles for article (PubMed ID: 27906780)
1. Developing a dedicated comprehensive α-radionuclide therapy program: should this be the vision of the atomic energy programs in the next decade?
Basu S; Banerjee S
Nucl Med Commun; 2017 Feb; 38(2):103-105. PubMed ID: 27906780
[No Abstract] [Full Text] [Related]
2. Envisaging an alpha therapy programme in the atomic energy establishments: the priorities and the nuances.
Basu S; Banerjee S
Eur J Nucl Med Mol Imaging; 2017 Jul; 44(7):1244-1246. PubMed ID: 28364163
[No Abstract] [Full Text] [Related]
3. The Evolving Clinical Role of Actinium-225 and Bismuth-213 for Targeted Alpha Therapy (TAT) - Production, Radiopharmaceutical Development and Clinical Applications.
Radchenko V; Schaffer P; Knapp FFR
Curr Radiopharm; 2018; 11(3):154-155. PubMed ID: 30378473
[No Abstract] [Full Text] [Related]
4. Nuclear energy and medicine: the Canadian connection.
Gray C
Can Med Assoc J; 1984 Feb; 130(3):299-304. PubMed ID: 6692215
[No Abstract] [Full Text] [Related]
5. [Trends in the use of radiopharamaceuticals in the Federal Republic of Germany].
Fogel' Iu
Med Radiol (Mosk); 1982 Aug; 27(8):69-71. PubMed ID: 7132606
[No Abstract] [Full Text] [Related]
6. Nuclear medicine. Scrambling to close the isotope gap.
Service RF
Science; 2011 Jan; 331(6015):277-9. PubMed ID: 21252324
[No Abstract] [Full Text] [Related]
7. Which radionuclide, carrier molecule and clinical indication for alpha-immunotherapy?
Guerard F; Barbet J; Chatal JF; Kraeber-Bodere F; Cherel M; Haddad F
Q J Nucl Med Mol Imaging; 2015 Jun; 59(2):161-7. PubMed ID: 25752501
[TBL] [Abstract][Full Text] [Related]
8. Potential and pitfalls of therapy with alpha-particles.
Welch MJ
J Nucl Med; 2005 Aug; 46(8):1254-5. PubMed ID: 16085579
[No Abstract] [Full Text] [Related]
9. Radiolanthanides in nuclear medicine.
Rösch F; Forssell-Aronsson E
Met Ions Biol Syst; 2004; 42():77-108. PubMed ID: 15206100
[No Abstract] [Full Text] [Related]
10. Targeted α therapy for cancer: where we are today and where we are heading.
Melville G
Future Oncol; 2015 Nov; 11(22):3065-7. PubMed ID: 26436906
[No Abstract] [Full Text] [Related]
11. Short- and long-term responses to molybdenum-99 shortages in nuclear medicine.
Ballinger JR
Br J Radiol; 2010 Nov; 83(995):899-901. PubMed ID: 20965898
[TBL] [Abstract][Full Text] [Related]
12. Energy Department proposes two isotope initiatives.
Rojas-Burke J
J Nucl Med; 1993 Jun; 34(6):47N-48N. PubMed ID: 8509849
[No Abstract] [Full Text] [Related]
13. TESLA Accelerator Installation at Vinca. Production of radioisotopes for nuclear-medical applications.
Vucina J; Memedović T; Vuksanović L
Med Pregl; 1993; 46 Suppl 1():103-4. PubMed ID: 8569591
[TBL] [Abstract][Full Text] [Related]
14. Report hints at restructuring of DOE isotope program.
Rojas-Burke J
J Nucl Med; 1993 Jun; 34(6):49N, 54N. PubMed ID: 8509850
[No Abstract] [Full Text] [Related]
15. Can α-radioimmunotherapy increase efficacy for the systemic control of cancer?
Allen BJ
Immunotherapy; 2011 Apr; 3(4):455-8. PubMed ID: 21463184
[No Abstract] [Full Text] [Related]
16. A report on the implementation aspects of the International Atomic Energy Agency's first doctoral coordinated research project, "Management of liver cancer using radionuclide methods with special emphasis on trans-arterial radio-conjugate therapy and internal dosimetry".
Padhy AK; Dondi M
Semin Nucl Med; 2008 Mar; 38(2):S5-12. PubMed ID: 18243843
[TBL] [Abstract][Full Text] [Related]
17. A review of the scientific highlights at the European Association of Nuclear Medicine Congress, Vienna 1991.
Fueger GF
Eur J Nucl Med; 1992; 19(4):287-305. PubMed ID: 1597246
[No Abstract] [Full Text] [Related]
18. [Future views in nuclear medicine].
Liewendahl K
Duodecim; 1993; 109(11):970-7. PubMed ID: 8062669
[No Abstract] [Full Text] [Related]
19. Energy Department molybdenum plan faltering.
J Nucl Med; 1993 Apr; 34(4):20N. PubMed ID: 8455070
[No Abstract] [Full Text] [Related]
20. The Energy Department's modest proposal.
Rojas-Burke J
J Nucl Med; 1993 Apr; 34(4):13N-14N, 17N-18N. PubMed ID: 8455069
[No Abstract] [Full Text] [Related]
[Next] [New Search]